Towards patient tailored cancer treatment supported by molecular imaging IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic Breast Cancer METcnummer: 2013/146 EudraCT nummer: 2013-000551041 Samenvatting Mogelijk zijn...
Watchful waiting in patients with good and intermediate risk metastatic renal cell carcinoma; an imaging guided observational approach. METcnummer: 2014.176 Onderzoekscode: O126 Samenvatting In een deel van de...
A phase III, open-label, multicenter, randomized study of atezolizumab (anti-PDL-L1 antibody) versus observation as adjuvant therapy in patients with high-risk muscle-invasive urothelial carcinoma after surgical resection Protocolnummer: WO29636...
Towards optimal treatment of inflammatory breast cancer patients Protocolnummer: BOOG 2014-05 METc nummer: 2014/345 Onderzoekscode: Samenvatting Inflammatoir mammacarcinoom (ook wel IBC, afgekort van “inflammatory breast cancer”) is...
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cells. METc nummer: 2017/395 Onderzoekscode t.b.v. borstkanker deel: O234 Samenvatting De...
Knowledge and attitudes regarding healthy lifestyle
12 april 2021
Knowledge and attitudes regarding healthy lifestyle and health behavior change in cancer patients and their partners; a pilot study Protocolnummer: 201501074 METc nummer: 2015.495 Samenvatting Kankerpatiënten krijgen tijdens...
The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS...
A Phase 1b/2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients with p53 Wild-Type (p53WT)Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy,...
Quality of life, cognitive function, and physical fitness of melanoma and NSCLC patients surviving more than 2 years after immune checkpoint inhibitor therapy Protocolnummer: 201800146 Eudract nummer: METc...
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients with Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer...
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer Protocolnummer: M12-914 EudraCT...
Safety, feasibility and cost-effectiveness of genotype-directed individualized dosing of fluoropyrimidines. Protocolnummer: M14DPD EudraCT nummer: 2014-005064-15 METc nummer: 2016/081 Onderzoekscode: Samenvatting In deze studie zal onderzocht worden of het...
M17TDM: Therapeutic drug monitoring for oral anti-cancer drugs Protocolnummer: M17TDM Samenvatting Orale doelgerichte medicijnen tegen kanker vormen een nieuwe groep geneesmiddelen. Op dit moment krijgen alle patiënten dezelfde...
Male Breast Cancer: prospective into perspective Protocolnummer: BOOG 2013-02 METc nummer: 2013/291 Samenvatting Ondanks het feit dat borstkanker bij mannen veel minder vaak voorkomt dan bij vrouwen, zijn...
Officiële titel: Measuring effects of high-fiber dried chicory root on the gut microbiota of patients with an intermediate to high-risk cutaneous melanoma: an explorative study. In de MELFIB...
